![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | increases expression | ISO | RGD:1319999 | 6480464 | Demecolcine results in increased expression of IRAK2 mRNA | CTD | PMID:23649840 | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1320000 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of IRAK2 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1320000 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IRAK2 mRNA | CTD | PMID:22206623 | 1-naphthyl isothiocyanate | multiple interactions | ISO | RGD:1319999 | 6480464 | [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of IRAK2 mRNA | CTD | PMID:27344345 | 17beta-estradiol | increases expression | ISO | RGD:1319999 | 6480464 | Estradiol results in increased expression of IRAK2 mRNA | CTD | PMID:20106945, PMID:31614463 | 17beta-estradiol | multiple interactions | ISO | RGD:1319999 | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of IRAK2 mRNA | CTD | PMID:30165855 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | RGD:1320000 | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | RGD:1320000 | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1320000 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IRAK2 mRNA | CTD | PMID:19933214 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IRAK2 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1320000 | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of IRAK2 mRNA | CTD | PMID:25975270 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1320000 | 6480464 | Tetrachlorodibenzodioxin affects the expression of IRAK2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of IRAK2 mRNA | CTD | PMID:32109520, PMID:34747641 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | ISO | RGD:1319999 | 6480464 | 2 more ... | CTD | PMID:26705709 | 4,4'-sulfonyldiphenol | increases expression | ISO | RGD:1320000 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased expression of IRAK2 mRNA | CTD | PMID:30951980 | 4,4'-sulfonyldiphenol | affects methylation | ISO | RGD:1320000 | 6480464 | bis(4-hydroxyphenyl)sulfone affects the methylation of IRAK2 gene | CTD | PMID:31683443 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of IRAK2 mRNA | CTD | PMID:24780913 | aflatoxin B1 | increases expression | ISO | RGD:1319999 | 6480464 | Aflatoxin B1 results in increased expression of IRAK2 mRNA | CTD | PMID:22100608 | aflatoxin B1 | increases methylation | ISO | RGD:1319999 | 6480464 | Aflatoxin B1 results in increased methylation of IRAK2 gene | CTD | PMID:27153756 | all-trans-retinoic acid | increases expression | ISO | RGD:1319999 | 6480464 | Tretinoin results in increased expression of IRAK2 mRNA | CTD | PMID:33167477 | amiodarone | increases expression | ISO | RGD:1319999 | 6480464 | Amiodarone results in increased expression of IRAK2 mRNA | CTD | PMID:19774075 | aripiprazole | multiple interactions | ISO | RGD:1319999 | 6480464 | Aripiprazole promotes the reaction [Ozone results in increased expression of IRAK2 mRNA] | CTD | PMID:31476115 | aristolochic acid A | increases expression | ISO | RGD:1319999 | 6480464 | aristolochic acid I results in increased expression of IRAK2 mRNA | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | ISO | RGD:1319999 | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to IRAK2 mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | affects expression | ISO | RGD:1319999 | 6480464 | Benzo(a)pyrene affects the expression of IRAK2 mRNA | CTD | PMID:21873647 | benzo[a]pyrene | affects methylation | ISO | RGD:1319999 | 6480464 | Benzo(a)pyrene affects the methylation of IRAK2 intron | CTD | PMID:30157460 | benzo[a]pyrene | increases methylation | ISO | RGD:1319999 | 6480464 | Benzo(a)pyrene results in increased methylation of IRAK2 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | RGD:1320000 | 6480464 | Benzo(a)pyrene results in increased expression of IRAK2 mRNA | CTD | PMID:22228805 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | RGD:1319999 | 6480464 | 7 more ... | CTD | PMID:19150397 | beta-naphthoflavone | increases expression | ISO | RGD:1319999 | 6480464 | beta-Naphthoflavone results in increased expression of IRAK2 mRNA | CTD | PMID:32151702 | beta-naphthoflavone | decreases expression | ISO | RGD:1319999 | 6480464 | beta-Naphthoflavone results in decreased expression of IRAK2 mRNA | CTD | PMID:32858204 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of IRAK2 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | RGD:1320000 | 6480464 | bisphenol A results in increased expression of IRAK2 mRNA | CTD | PMID:30951980 | bisphenol A | increases expression | ISO | RGD:1319999 | 6480464 | bisphenol A results in increased expression of IRAK2 mRNA | CTD | PMID:27685785 | bisphenol F | increases expression | ISO | RGD:1320000 | 6480464 | bisphenol F results in increased expression of IRAK2 mRNA | CTD | PMID:30951980 | bortezomib | increases expression | ISO | RGD:1319999 | 6480464 | Bortezomib results in increased expression of IRAK2 mRNA | CTD | PMID:20977926 | butanal | increases expression | ISO | RGD:1319999 | 6480464 | butyraldehyde results in increased expression of IRAK2 mRNA | CTD | PMID:26079696 | cadmium atom | increases expression | ISO | RGD:1319999 | 6480464 | Cadmium results in increased expression of IRAK2 mRNA | CTD | PMID:21120746 | cadmium atom | multiple interactions | ISO | RGD:1319999 | 6480464 | [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of IRAK2 mRNA | CTD | PMID:21481475 | cadmium selenide | multiple interactions | ISO | RGD:1319999 | 6480464 | [cadmium selenide co-treated with zinc sulfide] results in decreased expression of IRAK2 mRNA | CTD | PMID:22342292 | calcitriol | increases expression | ISO | RGD:1319999 | 6480464 | Calcitriol results in increased expression of IRAK2 mRNA | CTD | PMID:16002434 | carbon nanotube | increases expression | ISO | RGD:1319999 | 6480464 | Nanotubes, Carbon results in increased expression of IRAK2 mRNA | CTD | PMID:24389112 | carbon nanotube | increases expression | ISO | RGD:1320000 | 6480464 | Nanotubes, Carbon results in increased expression of IRAK2 mRNA | CTD | PMID:25554681 | carbon nanotube | affects expression | ISO | RGD:1320000 | 6480464 | Nanotubes, Carbon analog affects the expression of IRAK2 mRNA | CTD | PMID:25554681 | chlordecone | increases expression | ISO | RGD:1320000 | 6480464 | Chlordecone results in increased expression of IRAK2 mRNA | CTD | PMID:33711761 | chromium(6+) | affects expression | ISO | RGD:1320000 | 6480464 | chromium hexavalent ion affects the expression of IRAK2 mRNA | CTD | PMID:28472532 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of IRAK2 mRNA | CTD | PMID:24386269 | crocidolite asbestos | increases expression | ISO | RGD:1319999 | 6480464 | Asbestos, Crocidolite results in increased expression of IRAK2 mRNA | CTD | PMID:18687144 | crocidolite asbestos | decreases expression | ISO | RGD:1320000 | 6480464 | Asbestos, Crocidolite results in decreased expression of IRAK2 mRNA | CTD | PMID:29279043 | crocidolite asbestos | affects expression | ISO | RGD:1319999 | 6480464 | Asbestos, Crocidolite affects the expression of IRAK2 mRNA | CTD | PMID:24160326, PMID:25757056 | curcumin | multiple interactions | ISO | RGD:1319999 | 6480464 | Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of IRAK2 mRNA] | CTD | PMID:23452621 | cyclosporin A | increases expression | ISO | RGD:1319999 | 6480464 | Cyclosporine results in increased expression of IRAK2 mRNA | CTD | PMID:20106945, PMID:25562108 | dextran sulfate | multiple interactions | ISO | RGD:1320000 | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IRAK2 mRNA | CTD | PMID:29950665 | dibutyl phthalate | increases expression | ISO | RGD:1320000 | 6480464 | Dibutyl Phthalate results in increased expression of IRAK2 mRNA | CTD | PMID:17361019, PMID:21266533 | dicrotophos | increases expression | ISO | RGD:1319999 | 6480464 | dicrotophos results in increased expression of IRAK2 mRNA | CTD | PMID:28302478 | dioxygen | increases expression | ISO | RGD:1319999 | 6480464 | Oxygen deficiency results in increased expression of IRAK2 mRNA | CTD | PMID:23452621 | dioxygen | multiple interactions | ISO | RGD:1320000 | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IRAK2 mRNA | CTD | PMID:30529165 | dioxygen | multiple interactions | ISO | RGD:1319999 | 6480464 | 3 more ... | CTD | PMID:23452621 | doxorubicin | decreases expression | ISO | RGD:1319999 | 6480464 | Doxorubicin results in decreased expression of IRAK2 mRNA | CTD | PMID:29803840 | elemental selenium | multiple interactions | ISO | RGD:1319999 | 6480464 | [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of IRAK2 mRNA | CTD | PMID:21481475 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of IRAK2 mRNA | CTD | PMID:29391264 | ethyl methanesulfonate | increases expression | ISO | RGD:1319999 | 6480464 | Ethyl Methanesulfonate results in increased expression of IRAK2 mRNA | CTD | PMID:23649840 | fenofibrate | increases expression | ISO | RGD:1319999 | 6480464 | Fenofibrate results in increased expression of IRAK2 mRNA | CTD | PMID:25572481 | ferulic acid | multiple interactions | ISO | RGD:1320000 | 6480464 | ferulic acid inhibits the reaction [Imiquimod results in increased expression of IRAK2 mRNA] | CTD | PMID:31054998 | fluoranthene | multiple interactions | ISO | RGD:1320000 | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of IRAK2 mRNA | CTD | PMID:28329830 | folic acid | increases expression | ISO | RGD:1320000 | 6480464 | Folic Acid results in increased expression of IRAK2 mRNA | CTD | PMID:25629700 | folic acid | multiple interactions | ISO | RGD:1320000 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IRAK2 mRNA | CTD | PMID:22206623 | formaldehyde | increases expression | ISO | RGD:1319999 | 6480464 | Formaldehyde results in increased expression of IRAK2 mRNA | CTD | PMID:23649840 | gemcitabine | increases expression | ISO | RGD:1319999 | 6480464 | Gemcitabine results in increased expression of IRAK2 mRNA | CTD | PMID:17039268 | genistein | multiple interactions | ISO | RGD:1319999 | 6480464 | Genistein inhibits the reaction [Oxygen deficiency results in increased expression of IRAK2 mRNA] | CTD | PMID:23452621 | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of IRAK2 protein | CTD | PMID:24552547 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of IRAK2 mRNA | CTD | PMID:33387578 | glyphosate | decreases methylation | EXP | | 6480464 | glyphosate results in decreased methylation of IRAK2 gene | CTD | PMID:31011160 | graphite | affects expression | EXP | | 6480464 | Graphite affects the expression of IRAK2 mRNA | CTD | PMID:29933104 | imiquimod | multiple interactions | ISO | RGD:1320000 | 6480464 | ferulic acid inhibits the reaction [Imiquimod results in increased expression of IRAK2 mRNA] | CTD | PMID:31054998 | imiquimod | increases expression | ISO | RGD:1320000 | 6480464 | Imiquimod results in increased expression of IRAK2 mRNA | CTD | PMID:31054998 | lead(0) | affects expression | ISO | RGD:1319999 | 6480464 | Lead affects the expression of IRAK2 mRNA | CTD | PMID:28903495 | lead(2+) | affects expression | ISO | RGD:1319999 | 6480464 | Lead affects the expression of IRAK2 mRNA | CTD | PMID:28903495 | leflunomide | increases expression | ISO | RGD:1319999 | 6480464 | leflunomide results in increased expression of IRAK2 mRNA | CTD | PMID:28988120 | lidocaine | increases expression | EXP | | 6480464 | Lidocaine results in increased expression of IRAK2 mRNA | CTD | PMID:35283115 | lipopolysaccharide | increases expression | ISO | RGD:1320000 | 6480464 | Lipopolysaccharides results in increased expression of IRAK2 mRNA | CTD | PMID:25843059 | lipopolysaccharide | multiple interactions | ISO | RGD:1319999 | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of IRAK2 mRNA more ... | CTD | PMID:31059760, PMID:35811015 | lipopolysaccharide | multiple interactions | ISO | RGD:1320000 | 6480464 | 3 more ... | CTD | PMID:21291324, PMID:25843059 | lipopolysaccharide | increases expression | ISO | RGD:1319999 | 6480464 | Lipopolysaccharides results in increased expression of IRAK2 mRNA | CTD | PMID:18192897 more ... | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides co-treated with Titanium] results in increased expression of IRAK2 mRNA | CTD | PMID:21308757 | methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of IRAK2 mRNA | CTD | PMID:19564919 | methylisothiazolinone | increases expression | ISO | RGD:1319999 | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of IRAK2 mRNA | CTD | PMID:31629900 | mifepristone | decreases expression | ISO | RGD:1319999 | 6480464 | Mifepristone results in decreased expression of IRAK2 protein | CTD | PMID:17701593 | N-nitrosodiethylamine | decreases expression | ISO | RGD:1320000 | 6480464 | Diethylnitrosamine results in decreased expression of IRAK2 mRNA | CTD | PMID:18691550 | N-nitrosodiethylamine | multiple interactions | ISO | RGD:1320000 | 6480464 | MAPK14 protein inhibits the reaction [Diethylnitrosamine results in decreased expression of IRAK2 mRNA] | CTD | PMID:18691550 | N-Nitrosopyrrolidine | increases expression | ISO | RGD:1319999 | 6480464 | N-Nitrosopyrrolidine results in increased expression of IRAK2 mRNA | CTD | PMID:32234424 | nickel atom | increases expression | ISO | RGD:1319999 | 6480464 | Nickel results in increased expression of IRAK2 mRNA | CTD | PMID:23195993 | o-anisidine | affects expression | ISO | RGD:1319999 | 6480464 | 2-anisidine affects the expression of IRAK2 mRNA | CTD | PMID:28089782 | obeticholic acid | decreases expression | ISO | RGD:1319999 | 6480464 | obeticholic acid results in decreased expression of IRAK2 mRNA | CTD | PMID:27939613 | ozone | multiple interactions | ISO | RGD:1319999 | 6480464 | Aripiprazole promotes the reaction [Ozone results in increased expression of IRAK2 mRNA] | CTD | PMID:31476115 | ozone | increases expression | ISO | RGD:1319999 | 6480464 | Ozone results in increased expression of IRAK2 mRNA | CTD | PMID:31476115 | paracetamol | affects expression | ISO | RGD:1320000 | 6480464 | Acetaminophen affects the expression of IRAK2 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of IRAK2 mRNA | CTD | PMID:33387578 | paracetamol | increases expression | ISO | RGD:1319999 | 6480464 | Acetaminophen results in increased expression of IRAK2 mRNA | CTD | PMID:29067470, PMID:31059760 | paracetamol | multiple interactions | ISO | RGD:1319999 | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of IRAK2 mRNA | CTD | PMID:31059760 | PCB138 | multiple interactions | ISO | RGD:1320000 | 6480464 | [2 more ... | CTD | PMID:25510870 | pentanal | increases expression | ISO | RGD:1319999 | 6480464 | pentanal results in increased expression of IRAK2 mRNA | CTD | PMID:26079696 | perfluorononanoic acid | increases expression | ISO | RGD:1319999 | 6480464 | perfluoro-n-nonanoic acid results in increased expression of IRAK2 mRNA | CTD | PMID:32588087 | pirinixic acid | increases expression | ISO | RGD:1320000 | 6480464 | pirinixic acid results in increased expression of IRAK2 mRNA | CTD | PMID:18301758 | progesterone | increases expression | ISO | RGD:1319999 | 6480464 | Progesterone results in increased expression of IRAK2 protein | CTD | PMID:17701593 | progesterone | increases expression | ISO | RGD:1320000 | 6480464 | Progesterone results in increased expression of IRAK2 mRNA | CTD | PMID:21549006 | resveratrol | multiple interactions | ISO | RGD:1319999 | 6480464 | resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of IRAK2 mRNA] | CTD | PMID:23452621 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | RGD:1319999 | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | selenium atom | multiple interactions | ISO | RGD:1319999 | 6480464 | [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of IRAK2 mRNA | CTD | PMID:21481475 | serpentine asbestos | affects expression | ISO | RGD:1319999 | 6480464 | Asbestos, Serpentine affects the expression of IRAK2 mRNA | CTD | PMID:24160326 | silver atom | affects expression | ISO | RGD:1319999 | 6480464 | Silver affects the expression of IRAK2 mRNA | CTD | PMID:22342292 | silver(0) | affects expression | ISO | RGD:1319999 | 6480464 | Silver affects the expression of IRAK2 mRNA | CTD | PMID:22342292 | sodium arsenite | increases expression | ISO | RGD:1319999 | 6480464 | sodium arsenite results in increased expression of IRAK2 mRNA | CTD | PMID:29301061, PMID:34032870 | sodium arsenite | increases expression | ISO | RGD:1320000 | 6480464 | sodium arsenite results in increased expression of IRAK2 mRNA | CTD | PMID:36209798 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of IRAK2 mRNA | CTD | PMID:19281266 | sotorasib | multiple interactions | ISO | RGD:1319999 | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of IRAK2 mRNA | CTD | PMID:36139627 | succimer | multiple interactions | ISO | RGD:1320000 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IRAK2 mRNA | CTD | PMID:21641980 | sulindac | multiple interactions | EXP | | 6480464 | [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of IRAK2 mRNA | CTD | PMID:20371263 | sunitinib | decreases expression | ISO | RGD:1319999 | 6480464 | Sunitinib results in decreased expression of IRAK2 mRNA | CTD | PMID:31533062 | T-2 toxin | increases expression | ISO | RGD:1319999 | 6480464 | T-2 Toxin results in increased expression of IRAK2 mRNA | CTD | PMID:34581912 | tamibarotene | increases expression | ISO | RGD:1319999 | 6480464 | tamibarotene results in increased expression of IRAK2 mRNA | CTD | PMID:17229644 | temozolomide | decreases expression | ISO | RGD:1319999 | 6480464 | Temozolomide results in decreased expression of IRAK2 mRNA | CTD | PMID:31758290 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of IRAK2 mRNA | CTD | PMID:34492290 | titanium atom | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides co-treated with Titanium] results in increased expression of IRAK2 mRNA | CTD | PMID:21308757 | titanium dioxide | decreases expression | ISO | RGD:1319999 | 6480464 | titanium dioxide results in decreased expression of IRAK2 mRNA | CTD | PMID:22342292 | titanium dioxide | multiple interactions | ISO | RGD:1320000 | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IRAK2 mRNA | CTD | PMID:29950665 | trametinib | multiple interactions | ISO | RGD:1319999 | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of IRAK2 mRNA | CTD | PMID:36139627 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of IRAK2 mRNA | CTD | PMID:33387578 | triptonide | increases expression | ISO | RGD:1320000 | 6480464 | triptonide results in increased expression of IRAK2 mRNA | CTD | PMID:33045310 | troglitazone | increases expression | ISO | RGD:1319999 | 6480464 | troglitazone results in increased expression of IRAK2 mRNA | CTD | PMID:19140230 | urethane | increases expression | ISO | RGD:1319999 | 6480464 | Urethane results in increased expression of IRAK2 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | RGD:1320000 | 6480464 | Valproic Acid affects the expression of IRAK2 mRNA | CTD | PMID:17963808 | valproic acid | increases expression | ISO | RGD:1319999 | 6480464 | Valproic Acid results in increased expression of IRAK2 mRNA | CTD | PMID:23179753 | vincristine | increases expression | ISO | RGD:1319999 | 6480464 | Vincristine results in increased expression of IRAK2 mRNA | CTD | PMID:23649840 | zinc atom | multiple interactions | ISO | RGD:1319999 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of IRAK2 mRNA | CTD | PMID:18593933 | zinc(0) | multiple interactions | ISO | RGD:1319999 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of IRAK2 mRNA | CTD | PMID:18593933 | zoledronic acid | increases expression | ISO | RGD:1319999 | 6480464 | zoledronic acid results in increased expression of IRAK2 mRNA | CTD | PMID:24714768 | |